We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
TriPath Imaging and Ventana Medical Systems announced
TriPath has received 510(k) clearance from the FDA for the Ventana Image Analysis
System (VIAS) when used with tissues stained for Estrogen Receptor and Progesterone
Receptor.
MedMira, a company specializing in rapid flow-through diagnostic technology,
announced it has received approval from the FDA to provide new features in its
Reveal G2 Rapid HIV-1 Antibody Test.
Conor Medsystems announced that its UniStar cobalt chromium bare-metal coronary
stent received CE mark approval in the European Community for the treatment
of de novo coronary artery lesions.
Hospital groups have appealed to the FDA to take swift action on a February
2004 pledge to investigate and ultimately pursue a regulation requiring the
bar coding of medical devices.
InSite Vision -- an ophthalmic therapeutics, diagnostics and drug-delivery company
-- announced it has entered into definitive agreements for a $9 million private
financing of common stock and warrants for common stock.
In conjunction with the European Society of Human Genetics (ESHG) Annual Meeting,
Applied Biosystems Group, an Applera business, and Dartmouth Medical School
presented data using a preliminary version of Applied Biosystems TaqMan MicroRNA
(miRNA) Assays to profile microRNA expression in human brain cancer samples.
Biophan Technologies, a developer of next-generation medical technology, has
announced the filing of an SEC Form 8K/A report detailing its acquisition of
technology innovators aMRIs and MR Comp, two German companies conducting research
and development in advanced technologies involving magnetic resonance imaging
(MRI).